NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

The worst case scenario is FDA doesn’t approve revised endpoints and may reject the trial. But it’s clear that UK and Germany will approve. So just based on approval in these two regions, the market cap should be much higher than where we’re currently. So why would long term investors want to sell now? To me, this is an extremely safe investment. Plus someone commented that they saw Kevin Duffy during yesterday’s presentation. It’s clear Merck is super interested and a buyout will happen in the next 12 months if not sooner.